Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Cervix carcinoma
ADR ID BADD_A00870
ADR Hierarchy
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.12      Reproductive neoplasms female malignant and unspecified
16.12.01      Cervix neoplasms malignant
16.12.01.001      Cervix carcinoma
21      Reproductive system and breast disorders
21.06      Cervix disorders (excl infections and inflammations)
21.06.02      Cervix neoplasms
21.06.02.001      Cervix carcinoma
Description Tumors or cancer of the UTERINE CERVIX. [MeSH]
MedDRA Code 10008342
MeSH ID D002583
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Ca cervix | Carcinoma cervix | Carcinoma uterine cerix | Carcinoma uterine cervix | Cervical cancer | Cervical carcinoma NOS | Cervix carcinoma | Cervix uteri cancer | Malignant neoplasm of cervix uteri | Malignant neoplasm of cervix uteri, unspecified | Malignant neoplasm of endocervix | Malignant neoplasm of exocervix | Malignant neoplasm of other specified sites of cervix | Invasive cervix cancer | Papanicolaou smear abnormal, class V | Uterine Cervical Neoplasms | Cervical Neoplasm, Uterine | Cervical Neoplasms, Uterine | Neoplasm, Uterine Cervical | Neoplasms, Uterine Cervical | Uterine Cervical Neoplasm | Neoplasms, Cervical | Cervical Neoplasms | Cervical Neoplasm | Neoplasm, Cervical | Neoplasms, Cervix | Cervix Neoplasms | Cervix Neoplasm | Neoplasm, Cervix | Cancer of the Uterine Cervix | Cancer of the Cervix | Cervical Cancer | Uterine Cervical Cancer | Cancer, Uterine Cervical | Cancers, Uterine Cervical | Cervical Cancer, Uterine | Cervical Cancers, Uterine | Uterine Cervical Cancers | Cancer of Cervix | Cervix Cancer | Cancer, Cervix | Cancers, Cervix
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00142Anastrozole0.000318%
BADD_D00457Choriogonadotropin alfa--
BADD_D00474Cisplatin0.000168%
BADD_D00479Cladribine0.000229%
BADD_D00511Clozapine0.006726%
BADD_D00574Dalfampridine0.001184%
BADD_D00589Dasatinib0.000358%
BADD_D00680Dimethyl fumarate0.003601%
BADD_D00844Ethinyl estradiol--
BADD_D01136Imatinib0.000112%
BADD_D01281Levonorgestrel0.003309%
BADD_D01365Medroxyprogesterone--
BADD_D01366Medroxyprogesterone acetate--
BADD_D01418Methotrexate--
BADD_D01567Nilotinib0.000112%
BADD_D01629Osimertinib0.000112%
BADD_D01653Paclitaxel0.000112%
BADD_D01676Paricalcitol0.001962%
BADD_D01735Pergolide--
BADD_D01736Pergolide mesylate--
BADD_D01835Pregabalin0.000078%
BADD_D01913Ranitidine0.000663%
BADD_D01954Rivaroxaban0.000158%
BADD_D02165Teriflunomide0.000844%
BADD_D02213Tibolone--
BADD_D02236Tofacitinib0.001495%
BADD_D02375Water--
BADD_D02464Fingolimod0.004219%
BADD_D02500Alpelisib0.000112%
The 1th Page    1    Total 1 Pages